Soleus Capital Management, L.P.

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1802630 GREENWICH, CT

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$15,754,274

-$9,348,872 QoQ

Shares Held

246,353

-52.7% QoQ

Ownership

0.158%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

#42

of 264 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $361,941,334 across 8 Drug Manufacturers - Specialty & Generic names. KNSA ranks #7 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	225,587	$122,229,804
2	ANIP	Ani Pharmaceuticals Inc	867,760	$71,833,172
3	ALKS	Alkermes plc.	1,029,252	$53,932,804
4	INDV	Indivior Pharmaceuticals, Inc.	1,064,000	$43,655,920
5	ORGO	Organogenesis Holdings Inc.	10,140,951	$24,642,510
6	SUPN	Supernus Pharmaceuticals, Inc.	520,000	$24,185,200
7	KNSA	Kiniksa Pharmaceuticals International, plc This page	246,353	$15,754,274
8	EOLS	Evolus, Inc.	822,428	$5,707,650

All Filings in KNSA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,754,274	246,353	-52.7%	Shares	Sole	2026-08-11
2026-03-31	$25,103,146	521,353	-11.2%	Shares	Sole	2026-05-14
2025-12-31	$24,213,750	587,000	+291.3%	Shares	Sole	2026-02-12
2025-09-30	$5,824,500	150,000	-41.1%	Shares	Sole	2025-11-14
2025-06-30	$7,047,244	254,689	-45.8%	Shares	Sole	2025-08-15
2025-03-31	$10,427,595	469,500	+55.2%	Shares	Sole	2025-05-15
2024-09-30	$7,559,475	302,500	+51.2%	Shares	Sole	2024-11-14
2024-06-30	$3,734,000	200,000	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.